ARID1A and endometrial cancer: Approximately 6% of human cancers have ARID1A mutations that cause its inactivation, and these mutations are seen most frequently in clear cell ovarian cancers (~ 50%), endometrial cancers (~ 37%), gastric cancers (20–30%), and bladder cancers (~ 20%) s) [6–10].